The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Terry W. Moody

Cell & Cancer Biology Dept.

Medicine Branch

National Cancer Institute

Rockville

USA

[email]@bprb.nci.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Cell & Cancer Biology Dept., Medicine Branch, National Cancer Institute, Rockville, USA. 1998 - 2002
  • National Cancer Institute, Medicine Branch, Rockville, MD 20850, USA. 2002

References

  1. (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist. Moody, T.W., Jensen, R.T., Fridkin, M., Gozes, I. J. Mol. Neurosci. (2002) [Pubmed]
  2. Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats. Moody, T.W., Tuthill, C., Badamchian, M., Goldstein, A.L. Peptides (2002) [Pubmed]
  3. SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells. Moody, T.W., Chiles, J., Casibang, M., Moody, E., Chan, D., Davis, T.P. Peptides (2001) [Pubmed]
  4. Indomethacin reduces lung adenoma number in A/J mice. Moody, T.W., Leyton, J., Zakowicz, H., Hida, T., Kang, Y., Jakowlew, S., You, L., Ozbun, L., Zia, H., Youngberg, J., Malkinson, A. Anticancer Res. (2001) [Pubmed]
  5. VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells. Moody, T.W., Leyton, J., Chan, D., Brenneman, D.C., Fridkin, M., Gelber, E., Levy, A., Gozes, I. Breast Cancer Res. Treat. (2001) [Pubmed]
  6. CI-988 inhibits growth of small cell lung cancer cells. Moody, T.W., Jensen, R.T. J. Pharmacol. Exp. Ther. (2001) [Pubmed]
  7. Proadrenomedullin NH(2)-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells. Moody, T.W., Coy, D., Cuttitta, F., Montuenga, L.M. Peptides (2000) [Pubmed]
  8. Thymosinalpha1 is chemopreventive for lung adenoma formation in A/J mice. Moody, T.W., Leyton, J., Zia, F., Tuthill, C., Badamchian, M., Goldstein, A.L. Cancer Lett. (2000) [Pubmed]
  9. VPAC1 receptors and lung cancer. Moody, T.W., Walters, J., Casibang, M., Zia, F., Gozes, Y. Ann. N. Y. Acad. Sci. (2000) [Pubmed]
  10. (Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors. Moody, T.W., Leyton, J., Unsworth, E., John, C., Lang, L., Eckelman, W.C. Peptides (1998) [Pubmed]
  11. Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Moody, T.W., Leyton, J., Martinez, A., Hong, S., Malkinson, A., Mulshine, J.L. Exp. Lung Res. (1998) [Pubmed]
 
WikiGenes - Universities